Mannin Research Company
Mannin Research is collaborating with Q Biomed to use MAN-01, that is for treatment of Primary Open Angle Glaucoma, to ameliorate vessel damage in diseases that include “infectious diseases, such as influenza and the current coronavirus outbreak.
Technology:
COVID
Industry:
Treatments
Headquarters:
Canada
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership